CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning Balance at Dec. 31, 2022	$ 170,475	$ 22	$ 226,580	$ (95)	$ (56,032)
Beginning Balance, Shares at Dec. 31, 2022		21,920,402
Exercise of common stock options, Shares		232
Stock-based compensation expense	2,646		2,646
Unrealized gain on available-for-sale investments, net of tax	104			104
Net loss	(12,756)				(12,756)
Ending Balance at Mar. 31, 2023	160,469	$ 22	229,226	9	(68,788)
Ending Balance, Shares at Mar. 31, 2023		21,920,634
Beginning Balance at Dec. 31, 2023	121,195	$ 23	237,675	(83)	(116,420)
Beginning Balance, Shares at Dec. 31, 2023		22,522,644
Exercise of common stock options	$ 79		79
Exercise of common stock options, Shares	20,277	20,277
Issuance of common stock upon vesting of restricted stock units, net of shares withheld for tax	$ (166)		(166)
Issuance of common stock upon vesting of restricted stock units, net of shares withheld for tax, Shares		94,618
Stock-based compensation expense	3,344		3,344
Unrealized gain on available-for-sale investments, net of tax	13			13
Net loss	(16,486)				(16,486)
Ending Balance at Mar. 31, 2024	$ 107,979	$ 23	$ 240,932	$ (70)	$ (132,906)
Ending Balance, Shares at Mar. 31, 2024		22,637,539